ID   TBK1_HUMAN              Reviewed;         729 AA.
AC   Q9UHD2; A8K4S4; Q8IYV3; Q9NUJ5;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-NOV-2010, entry version 85.
DE   RecName: Full=Serine/threonine-protein kinase TBK1;
DE            EC=2.7.11.1;
DE   AltName: Full=NF-kappa-B-activating kinase;
DE   AltName: Full=T2K;
DE   AltName: Full=TANK-binding kinase 1;
GN   Name=TBK1; Synonyms=NAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH TANK AND TRAF2,
RP   AND MUTAGENESIS OF LYS-38.
RC   TISSUE=Spleen;
RX   MEDLINE=20050564; PubMed=10581243; DOI=10.1093/emboj/18.23.6694;
RA   Pomerantz J.L., Baltimore D.;
RT   "NF-kB activation by a signaling complex containing TRAF2, TANK, and
RT   TBK1, a novel IKK-related kinase.";
RL   EMBO J. 18:6694-6704(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   MEDLINE=20244479; PubMed=10783893; DOI=10.1038/35008109;
RA   Tojima Y., Fujimoto A., Delhase M., Chen Y., Hatakeyama S.,
RA   Nakayama K., Kaneko Y., Nimura Y., Motoyama N., Ikeda K., Karin M.,
RA   Nakanishi M.;
RT   "NAK is an IkappaB kinase-activating kinase.";
RL   Nature 404:778-782(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASP-388 AND
RP   GLN-570.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, MUTAGENESIS OF SER-172, AND PHOSPHORYLATION AT SER-172.
RX   PubMed=11839743; DOI=10.1074/jbc.M110474200;
RA   Kishore N., Huynh Q.K., Mathialagan S., Hall T., Rouw S., Creely D.,
RA   Lange G., Caroll J., Reitz B., Donnelly A., Boddupalli H., Combs R.G.,
RA   Kretzmer K., Tripp C.S.;
RT   "IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme
RT   IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and
RT   IKK-2.";
RL   J. Biol. Chem. 277:13840-13847(2002).
RN   [7]
RP   INTERACTION WITH TIRAP AND TICAM1.
RX   PubMed=14530355;
RA   Sato S., Sugiyama M., Yamamoto M., Watanabe Y., Kawai T., Takeda K.,
RA   Akira S.;
RT   "Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)
RT   associates with TNF receptor-associated factor 6 and TANK-binding
RT   kinase 1, and activates two distinct transcription factors, NF-kappa B
RT   and IFN-regulatory factor-3, in the Toll-like receptor signaling.";
RL   J. Immunol. 171:4304-4310(2003).
RN   [8]
RP   FUNCTION.
RX   PubMed=12692549; DOI=10.1038/ni921;
RA   Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E.,
RA   Golenbock D.T., Coyle A.J., Liao S.-M., Maniatis T.;
RT   "IKKepsilon and TBK1 are essential components of the IRF3 signaling
RT   pathway.";
RL   Nat. Immunol. 4:491-496(2003).
RN   [9]
RP   FUNCTION.
RX   PubMed=12702806; DOI=10.1126/science.1081315;
RA   Sharma S., tenOever B.R., Grandvaux N., Zhou G.-P., Lin R.,
RA   Hiscott J.;
RT   "Triggering the interferon antiviral response through an IKK-related
RT   pathway.";
RL   Science 300:1148-1151(2003).
RN   [10]
RP   INTERACTION WITH AZI2.
RX   MEDLINE=22921922; PubMed=14560022;
RX   DOI=10.1128/MCB.23.21.7780-7793.2003;
RA   Fujita F., Taniguchi Y., Kato T., Narita Y., Furuya A., Ogawa T.,
RA   Sakurai H., Joh T., Itoh M., Delhase M., Karin M., Nakanishi M.;
RT   "Identification of NAP1, a regulatory subunit of IkappaB kinase-
RT   related kinases that potentiates NF-kappaB signaling.";
RL   Mol. Cell. Biol. 23:7780-7793(2003).
RN   [11]
RP   INTERACTION WITH TICAM1.
RX   PubMed=14739303; DOI=10.1074/jbc.M311629200;
RA   Han K.J., Su X., Xu L.-G., Bin L.H., Zhang J., Shu H.-B.;
RT   "Mechanisms of the TRIF-induced interferon-stimulated response element
RT   and NF-kappaB activation and apoptosis pathways.";
RL   J. Biol. Chem. 279:15652-15661(2004).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15485837; DOI=10.1074/jbc.M411037200;
RA   Kuai J., Wooters J., Hall J.P., Rao V.R., Nickbarg E., Li B.,
RA   Chatterjee-Kishore M., Qiu Y., Lin L.-L.;
RT   "NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner
RT   and mediates the production of RANTES: identification of endogenous
RT   TNFR-interacting proteins by a proteomic approach.";
RL   J. Biol. Chem. 279:53266-53271(2004).
RN   [13]
RP   INTERACTION WITH SIKE1; IRF3; TICAM1 AND DDX58.
RX   PubMed=16281057; DOI=10.1038/sj.emboj.7600863;
RA   Huang J., Liu T., Xu L.-G., Chen D., Zhai Z., Shu H.-B.;
RT   "SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-
RT   triggered IRF-3 activation pathways.";
RL   EMBO J. 24:4018-4028(2005).
RN   [14]
RP   INTERACTION WITH HCV NS3.
RX   PubMed=15841462; DOI=10.1002/hep.20666;
RA   Otsuka M., Kato N., Moriyama M., Taniguchi H., Wang Y., Dharel N.,
RA   Kawabe T., Omata M.;
RT   "Interaction between the HCV NS3 protein and the host TBK1 protein
RT   leads to inhibition of cellular antiviral responses.";
RL   Hepatology 41:1004-1012(2005).
RN   [15]
RP   INTERACTION WITH BORNA DISEASE VIRUS P PROTEIN.
RX   PubMed=16155125; DOI=10.1073/pnas.0502883102;
RA   Unterstab G., Ludwig S., Anton A., Planz O., Dauber B., Krappmann D.,
RA   Heins G., Ehrhardt C., Wolff T.;
RT   "Viral targeting of the interferon-beta-inducing Traf family member-
RT   associated NF-kappa-B activator (TANK)-binding kinase-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13640-13645(2005).
RN   [16]
RP   INTERACTION WITH CYLD.
RX   PubMed=18636086; DOI=10.1038/embor.2008.136;
RA   Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A.,
RA   Cardenas W.B., Yount J.S., Moran T.M., Basler C.F., Komuro A.,
RA   Horvath C.M., Xavier R., Ting A.T.;
RT   "The tumour suppressor CYLD is a negative regulator of RIG-I-mediated
RT   antiviral response.";
RL   EMBO Rep. 9:930-936(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-716, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172; SER-509; SER-510
RP   AND SER-716, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   INTERACTION WITH OPTN AND TRAF3.
RX   PubMed=20174559; DOI=10.1371/journal.ppat.1000778;
RA   Mankouri J., Fragkoudis R., Richards K.H., Wetherill L.F., Harris M.,
RA   Kohl A., Elliott R.M., Macdonald A.;
RT   "Optineurin negatively regulates the induction of IFNbeta in response
RT   to RNA virus infection.";
RL   PLoS Pathog. 6:E1000778-E1000778(2010).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-271; GLU-291; HIS-296; ARG-410 AND
RP   ALA-464.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein involved in the signaling
CC       cascade converging to the activation of the transcription factor
CC       NF-kappa-B. May function as an IKK kinase, playing an essential
CC       role in the transcription of a subset of TNF-alpha-induced genes.
CC       Also mediates production of RANTES/CCL5 and interferon-beta/IFNB1.
CC       Has a pivotal role in the innate immune response. Phosphorylates
CC       Borna disease virus (BDV) P protein. Phosphorylates and activates
CC       IRF3 and IRF7 and allows their nuclear localization. This leads to
CC       production of alpha/beta interferons and the development of a
CC       cellular antiviral state. It also seems to be a central factor in
CC       the induction of the antiviral interferon response. Inhibition of
CC       its interaction with IRF3, due to HCV NS3 binding or BDV P protein
CC       seems to be one mechanism of inhibition of the innate immune
CC       responses of hepatitis C virus (HCV) infection or Borna disease
CC       virus infection respectively.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with TIRAP, TANK and TRAF2. Part of a ternary
CC       complex consisting of TANK, TRAF2 and TBK1. Interacts with AZI2.
CC       Interacts with SIKE1. Interacts with TICAM1/TRIF, IRF3 and
CC       DDX58/RIG-I, interactions are disrupted by the interaction between
CC       TBK1 and SIKE1. Interacts with CYLD. Interacts with HCV NS3, a
CC       hepatitis C virus protein and with BDV P protein, a Borna disease
CC       virus protein. Interacts with OPTN and TRAF3.
CC   -!- INTERACTION:
CC       P98170:XIAP; NbExp=1; IntAct=EBI-356402, EBI-517127;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Ubiquitous with higher expression in testis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. I-kappa-B kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92129.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF191838; AAF05989.1; -; mRNA.
DR   EMBL; AF174536; AAF69106.1; -; mRNA.
DR   EMBL; AK002192; BAA92129.1; ALT_INIT; mRNA.
DR   EMBL; AK291039; BAF83728.1; -; mRNA.
DR   EMBL; CH471054; EAW97133.1; -; Genomic_DNA.
DR   EMBL; BC034950; AAH34950.1; -; mRNA.
DR   IPI; IPI00293613; -.
DR   RefSeq; NP_037386.1; -.
DR   UniGene; Hs.505874; -.
DR   UniGene; Hs.607889; -.
DR   ProteinModelPortal; Q9UHD2; -.
DR   SMR; Q9UHD2; 11-240.
DR   DIP; DIP-27529N; -.
DR   IntAct; Q9UHD2; 58.
DR   MINT; MINT-1131333; -.
DR   STRING; Q9UHD2; -.
DR   PhosphoSite; Q9UHD2; -.
DR   PeptideAtlas; Q9UHD2; -.
DR   PRIDE; Q9UHD2; -.
DR   Ensembl; ENST00000331710; ENSP00000329967; ENSG00000183735.
DR   GeneID; 29110; -.
DR   KEGG; hsa:29110; -.
DR   UCSC; uc001ssc.1; human.
DR   CTD; 29110; -.
DR   GeneCards; GC12P064845; -.
DR   H-InvDB; HIX0201827; -.
DR   HGNC; HGNC:11584; TBK1.
DR   MIM; 604834; gene.
DR   PharmGKB; PA36348; -.
DR   eggNOG; prNOG18487; -.
DR   HOGENOM; HBG446298; -.
DR   HOVERGEN; HBG008494; -.
DR   InParanoid; Q9UHD2; -.
DR   OMA; FSLQQMT; -.
DR   OrthoDB; EOG9K3PG0; -.
DR   PhylomeDB; Q9UHD2; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 52179; -.
DR   ArrayExpress; Q9UHD2; -.
DR   Bgee; Q9UHD2; -.
DR   CleanEx; HS_TBK1; -.
DR   Genevestigator; Q9UHD2; -.
DR   GermOnline; ENSG00000183735; Homo sapiens.
DR   GO; GO:0010008; C:endosome membrane; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB cascade; EXP:Reactome.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; IEP:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0009615; P:response to virus; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Antiviral defense; ATP-binding; Coiled coil; Complete proteome;
KW   Cytoplasm; Host-virus interaction; Immunity; Innate immunity; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    729       Serine/threonine-protein kinase TBK1.
FT                                /FTId=PRO_0000086743.
FT   DOMAIN        9    310       Protein kinase.
FT   NP_BIND      15     23       ATP (By similarity).
FT   COILED      626    713       Potential.
FT   ACT_SITE    135    135       Proton acceptor (By similarity).
FT   BINDING      38     38       ATP (By similarity).
FT   MOD_RES     172    172       Phosphoserine; by autocatalysis.
FT   MOD_RES     509    509       Phosphoserine.
FT   MOD_RES     510    510       Phosphoserine.
FT   MOD_RES     716    716       Phosphoserine.
FT   VARIANT     271    271       R -> Q (in dbSNP:rs56196591).
FT                                /FTId=VAR_041208.
FT   VARIANT     291    291       K -> E (in dbSNP:rs34774243).
FT                                /FTId=VAR_041209.
FT   VARIANT     296    296       D -> H (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041210.
FT   VARIANT     388    388       N -> D (in dbSNP:rs17857028).
FT                                /FTId=VAR_024746.
FT   VARIANT     410    410       G -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041211.
FT   VARIANT     464    464       V -> A (in dbSNP:rs35635889).
FT                                /FTId=VAR_041212.
FT   VARIANT     570    570       K -> Q (in dbSNP:rs17853341).
FT                                /FTId=VAR_024747.
FT   MUTAGEN      38     38       K->A: Loss of TANK-mediated NF-kappa-B
FT                                activation.
FT   MUTAGEN     172    172       S->A: Loss of kinase activity.
FT   MUTAGEN     172    172       S->E: Decreased kinase activity.
SQ   SEQUENCE   729 AA;  83642 MW;  B58E4FE1B502276D CRC64;
     MQSTSNHLWL LSDILGQGAT ANVFRGRHKK TGDLFAIKVF NNISFLRPVD VQMREFEVLK
     KLNHKNIVKL FAIEEETTTR HKVLIMEFCP CGSLYTVLEE PSNAYGLPES EFLIVLRDVV
     GGMNHLRENG IVHRDIKPGN IMRVIGEDGQ SVYKLTDFGA ARELEDDEQF VSLYGTEEYL
     HPDMYERAVL RKDHQKKYGA TVDLWSIGVT FYHAATGSLP FRPFEGPRRN KEVMYKIITG
     KPSGAISGVQ KAENGPIDWS GDMPVSCSLS RGLQVLLTPV LANILEADQE KCWGFDQFFA
     ETSDILHRMV IHVFSLQQMT AHKIYIHSYN TATIFHELVY KQTKIISSNQ ELIYEGRRLV
     LEPGRLAQHF PKTTEENPIF VVSREPLNTI GLIYEKISLP KVHPRYDLDG DASMAKAITG
     VVCYACRIAS TLLLYQELMR KGIRWLIELI KDDYNETVHK KTEVVITLDF CIRNIEKTVK
     VYEKLMKINL EAAELGEISD IHTKLLRLSS SQGTIETSLQ DIDSRLSPGG SLADAWAHQE
     GTHPKDRNVE KLQVLLNCMT EIYYQFKKDK AERRLAYNEE QIHKFDKQKL YYHATKAMTH
     FTDECVKKYE AFLNKSEEWI RKMLHLRKQL LSLTNQCFDI EEEVSKYQEY TNELQETLPQ
     KMFTASSGIK HTMTPIYPSS NTLVEMTLGM KKLKEEMEGV VKELAENNHI LERFGSLTMD
     GGLRNVDCL
//
